Latest News
- Details
August’s paper of the month looks at the PRODIGE-7 trial, a multicentre randomised open-label, phase 3 trial which sought to determine whether hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreductive surgery for colorectal peritoneal metastases
- Details
Gabriela Möslein is ESCP's Assistant Programme Committee Chair and Director of the Center for Hereditary Tumors at BETHESDA Khs. Duisburg in Germany.
- Details
David Zimmerman is ESCP's representative on the European Union of Medical Specialists, and colorectal surgeon at Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
- Details
Oded Zmora is ESCP's President Elect. He is a Professor at Shamir Medical Center, Tel Aviv, Israel.
- Details
ESCP to conduct new research following investigation into the environmental impact of surgical practice